Expert Voices in Dementia

The Need for Compassion in a Dementia Diagnosis

Daniel C. Potts, MD, FAAN, Attending Neurologist at the Tuscaloosa VA Medical Center speaks with Marie Marley, PhD, author of the award-winning book Come Back Early Today

The Caregiver Journey - Resources and Recommendations for Neurologists

Daniel C. Potts, MD, FAAN, Attending Neurologist at the Tuscaloosa VA Medical Center speaks with Marie Marley, PhD, author of the award-winning book Come Back Early Today

Clinician-Reported Factors Influencing Cognitive Evaluations in Primary Care

Kyra O'Brien, MD, Assistant Professor of Neurology at the Hospital of the University of Pennsylvania discusses modifiable barriers to performing cognitive evaluations in

Key Takeaways from AAIC 2025: Lifestyle Modifications, Biomarkers, Amyloid-Targeting Therapies, and More

Ana C. Pereira, MD, Associate Professor, Icahn School of Medicine at Mount Sinai, New York, NY, discusses key takeaways about the impact of patient lifestyle modification

The Brain Health Navigator: A Novel Program to Improve Alzheimer Disease Care

Gregory E. Cooper, MD, PhD, Director, Memory Center, Norton Neuroscience Institute, Louisville, KY, outlines the Brain Health Navigator program as a strategy to streamlin

Beyond Slowing Cognitive Decline: Patient and Caregiver Perspectives on Alzheimer’s Treatment

This episode explores groundbreaking qualitative research from the University of Pennsylvania on patient and caregiver perspectives in Alzheimer disease. Dr. Katie Auriem

Beyond the Boardroom: Barbara Corcoran on Caregiving and Alzheimer Disease

In this episode, we are joined by entrepreneur and television personality, Barbara Corcoran. While many know Barbara for her business acumen and dynamic presence on Shark

Plasma P-Tau217: Detecting Alzheimer Disease with a Blood Test

Sterling Johnson, PhD, Associate Director and Biomarker Core Leader in the Wisconsin Alzheimer’s Disease Research Center (ADRC), and a Clinical Neuropsychologist and Neur

Updated Criteria for Diagnosis and Staging of Alzheimer Disease: Recommendations of the International Working Group

Nicolas Villain, MD, PhD, Associate Professor of Neurology, Sorbonne University, Paris, France, discusses the International Working Group’s updated diagnostic criteria fo

Blarcamesine: An Investigational Oral Drug for Alzheimer Disease

Timo Grimmer, MD, Associate Professor of Psychiatry and Psychotherapy and Head of the Centre for Cognitive Disorders at the Technical University of Munich, Germany, discu

The CMS GUIDE Model To Support Patients with Dementia and Their Caregivers

Sarena Ho, Health Insurance Specialist at the CMS Innovation Center, provides an overview on the Guiding an Improved Dementia Experience (GUIDE) Model, which helps physic

The BenfoTeam Clinical Trial: Investigating Benfotiamine as a Potential Therapy for Early Alzheimer Disease

Gary E. Gibson, PhD, Professor of Neurosciences, Burke Neurological Institute, Weill Cornell Medicine, White Plains, NY, details his research related to metabolic changes

BrainCheck as a Digital Cognitive Assessment Tool

Kim Rodriguez, CEO of BrainCheck, provides an overview of the company's cognitive assessment plan and how clinicians can use these tools in practice. Learn more about you

Kramer, Van Dyck

Lynn D. Kramer, MD, FAAN, Chief Clinical Officer, Deep Human Biology Learning at Eisai and a member of the Eisai Executive Committee, and Christopher van Dyck, MD, Profes

CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 3

In this series, Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses cerebrospinal fluid, PET,

CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 2

In this series, Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses cerebrospinal fluid, PET,

CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 1

In this series, Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses cerebrospinal fluid, PET,

Labcorp's Biomarker Testing for Alzheimer Disease

Joseph M. Volpe, MD, Discipline Director, Clinical Neuroscience, Labcorp, discusses biomarker testing for Alzheimer disease and dementia,, including current offerings, re

What Neurologists Should Know About End-of-Life Care Discussions

Dan Morhaim, MD, board-certified emergency medicine and internal medicine physician, and former 24-year Maryland State Legislator, highlights the importance of discussing

Insights into the Role of Tau in Alzheimer Disease and Neurodegenerative Disorders

Virginia Man-Yee Lee, PhD, who serves as the John H. Ware 3rd Endowed Professor in Alzheimer's Research at the University of Pennsylvania Perelman School of Medicine, the